Westchester Capital Management (New York)’s Organogenesis Holdings ORGO Stock Holding History

Westchester Capital Management (New York)’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,053,000	Closed	-$10.7M	–	123
2018 Q3	$10.7M	Hold	1,053,000	–	–	0.41%	35
2018 Q2	$10.6M	Hold	1,053,000	–	–	0.42%	33
2018 Q1	$10.5M	Hold	1,053,000	–	–	0.41%	33
2017 Q4	$10.4M	Buy	1,053,000 +1,000,000	+1,887%	+$9.93M	0.41%	33
2017 Q3	$530K	Buy	+53,000	New	+$526K	0.02%	72

Westchester Capital Management (New York)'s ORGO Position: Q4 2018 in Review

Westchester Capital Management (New York) sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 1,053,000 shares — an estimated $10.7M sold.

Westchester Capital Management (New York) first reported a position in ORGO in Q3 2017 and held it in 5 quarters. The position peaked at $10.7M in Q3 2018. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

Westchester Capital Management (New York) reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
Westchester Capital Management (New York) sold 1,053,000 Organogenesis Holdings shares in Q4 2018, an estimated $10.7M.
Westchester Capital Management (New York) first reported a position in Organogenesis Holdings in Q3 2017 and held it in 5 quarters.
Westchester Capital Management (New York)'s Organogenesis Holdings position peaked at $10.7M in Q3 2018.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2018, filed 14 Feb 2019.